Ralph Snyderman, MD, is Chancellor Emeritus, Duke University, James B. Duke Professor of Medicine, and Director of the Center for Research in Personalized Health Care at the Duke University School of Medicine. He previously served as Chancellor for Health Affairs at Duke University and as the founding President and CEO of the Duke University Health System; Dean of the School of Medicine at Duke University; Chair of the Association of American Medical Colleges; Senior Vice President, Medical Research and Development, Genentech, Inc.; Director, Laboratory of Immune Effector Function, Howard Hughes Medical Institute; Chief, Division of Rheumatology and Immunology at Duke; and Senior Investigator, National Institutes of Health. Dr. Snyderman has received numerous honors, including the Personalized Medicine World Conference Pioneer Award (2016), the North Carolina Life Sciences Leadership Award (2014), the Association of American Medical Colleges David E. Rogers Award (2012), the Industr
Personalizing Health Care
-
Published:October 2016
The genomics revolution, in which Dr. Snyderman had participated at Genentech with the sequencing of the human genome was going to transform medicine by allowing it to be more personalized and preventative. Dr. Snyderman envisioned a bold new approach termed personalized health care. Duke foresaw this and pioneered programs in personalized medicine. Perverse reimbursement incentives made broad application untenable. However, Duke’s efforts were nationally noted and spurred health care reform.
Advertisement
